secwatch.observer — SEC 8-K summary ====================================== Issuer: ASP Isotopes Inc. (ASPI) CIK: 0001921865 Form: 8-K Filed at: 2026-10-15T12:22:40+00:00 Accession: 0001193125-26-422325 Event type: other_material Sentiment: positive Materiality: 0.60 Item codes: 7.01, 9.01 LLM model: deepseek-v4.1-flash:cloud@v2 ASP Isotopes unit QLE signs binding HALEU joint-venture agreement with South Africa's Necsa -------------------------------------------------------------------------------- - QLE will hold approximately 80% of the Joint Venture and lead operations and capital raising; Necsa holds approximately 20%, contributing site access, safeguards and licensing support. - The Joint Venture will develop, finance, construct, commission and operate a test bench and commercial-scale HALEU production facility at Necsa's Pelindaba site in South Africa. - Offtake for the expected HALEU output is already secured through supply agreements with TerraPower, described as a leading advanced nuclear reactor developer. - Prior milestones: MOU in November 2024, Pre-Implementation Services Contract in February 2026, and July 2026 approval from South Africa's Ministry of Electricity and Energy. - Necsa's Pelindaba headquarters hosts the 20MW SAFARI-1 research reactor; the parties intend an EPC arrangement giving the project access to Necsa's engineering capabilities. Source: EDGAR index: https://www.sec.gov/Archives/edgar/data/1921865/000119312526422325/0001193125-26-422325-index.htm Primary doc: https://www.sec.gov/Archives/edgar/data/1921865/000119312526422325/aspi-20261015.htm HTML page: https://secwatch.observer/filing/0001193125-26-422325 License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer